Search

Showing results for: AUTHOR - Handunnetti, SM

Found: 3 results

Immune recovery in patients with mantle cell lymphoma receiving long-term ibrutinib and venetoclax combination therapy Blood Adv - 2020-10-13 Davis, JE; Handunnetti, SM; Ludford-Menting, M; Sharpe, C; Blombery, P; Anderson, MA; Roberts, AW; Seymour, JF; Tam, CS; Ritchie, DS; Koldej, RM
Link to Open Access at Publisher's Site Download PDF
BTK inhibitor therapy is effective in patients with CLL resistant to venetoclax Blood - 2020-04-03 Lin, VS; Lew, TE; Handunnetti, SM; Blombery, P; Nguyen, T; Westerman, DA; Kuss, BJ; Tam, C; Roberts, AW; Seymour, JF; Anderson, MA
Link to Open Access at Publisher's Site
Undetectable peripheral blood MRD should be the goal of venetoclax in CLL, but attainment plateaus after 24 months Blood Advances - 2020-01-14 Lew, TE; Anderson, MA; Lin, VS; Handunnetti, SM; Came, NA; Blombery, P; Westerman, DA; Wall, M; Tam, CS; Roberts, AW; Seymour, JF
Link to Open Access at Publisher's Site Download PDF
An error has occurred. This application may no longer respond until reloaded. Reload 🗙